168 related articles for article (PubMed ID: 34994648)
1. Up-Front Multigene Panel Testing for Cancer Susceptibility in Patients With Newly Diagnosed Endometrial Cancer: A Multicenter Prospective Study.
Levine MD; Pearlman R; Hampel H; Cosgrove C; Cohn D; Chassen A; Suarez A; Barrington DA; McElroy JP; Waggoner S; Nakayama J; Billingsley C; Resnick K; Andrews S; Singh S; Jenison E; Clements A; Neff R; Goodfellow PJ;
JCO Precis Oncol; 2021 Nov; 5():1588-1602. PubMed ID: 34994648
[TBL] [Abstract][Full Text] [Related]
2. Implementing universal upfront multi-gene panel testing in endometrial cancer: From cost to practical considerations.
Levine MD; Barrington DA; Hampel H; Goodfellow PJ; Cohn DE
Gynecol Oncol; 2022 Sep; 166(3):538-542. PubMed ID: 35871048
[TBL] [Abstract][Full Text] [Related]
3. Utility of germline multi-gene panel testing in patients with endometrial cancer.
Karpel HC; Chern JY; Smith J M; Smith A J; Pothuri B
Gynecol Oncol; 2022 Jun; 165(3):546-551. PubMed ID: 35483985
[TBL] [Abstract][Full Text] [Related]
4. A clinical guide to hereditary cancer panel testing: evaluation of gene-specific cancer associations and sensitivity of genetic testing criteria in a cohort of 165,000 high-risk patients.
LaDuca H; Polley EC; Yussuf A; Hoang L; Gutierrez S; Hart SN; Yadav S; Hu C; Na J; Goldgar DE; Fulk K; Smith LP; Horton C; Profato J; Pesaran T; Gau CL; Pronold M; Davis BT; Chao EC; Couch FJ; Dolinsky JS
Genet Med; 2020 Feb; 22(2):407-415. PubMed ID: 31406321
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Colorectal and Endometrial Microsatellite Instability Tumor Analysis and Premm
Mannucci A; Furniss CS; Ukaegbu C; Horiguchi M; Fehlmann T; Uno H; Yurgelun MB; Syngal S
J Clin Oncol; 2020 Dec; 38(34):4086-4094. PubMed ID: 32997573
[TBL] [Abstract][Full Text] [Related]
6. The proportion of endometrial tumours associated with Lynch syndrome (PETALS): A prospective cross-sectional study.
Ryan NAJ; McMahon R; Tobi S; Snowsill T; Esquibel S; Wallace AJ; Bunstone S; Bowers N; Mosneag IE; Kitson SJ; O'Flynn H; Ramchander NC; Sivalingam VN; Frayling IM; Bolton J; McVey RJ; Evans DG; Crosbie EJ
PLoS Med; 2020 Sep; 17(9):e1003263. PubMed ID: 32941469
[TBL] [Abstract][Full Text] [Related]
7. Cancer susceptibility gene mutations in type I and II endometrial cancer.
Long B; Lilyquist J; Weaver A; Hu C; Gnanaolivu R; Lee KY; Hart SN; Polley EC; Bakkum-Gamez JN; Couch FJ; Dowdy SC
Gynecol Oncol; 2019 Jan; 152(1):20-25. PubMed ID: 30612635
[TBL] [Abstract][Full Text] [Related]
8. Male breast cancer in a multi-gene panel testing cohort: insights and unexpected results.
Pritzlaff M; Summerour P; McFarland R; Li S; Reineke P; Dolinsky JS; Goldgar DE; Shimelis H; Couch FJ; Chao EC; LaDuca H
Breast Cancer Res Treat; 2017 Feb; 161(3):575-586. PubMed ID: 28008555
[TBL] [Abstract][Full Text] [Related]
9. Germline multi-gene hereditary cancer panel testing in an unselected endometrial cancer cohort.
Ring KL; Bruegl AS; Allen BA; Elkin EP; Singh N; Hartman AR; Daniels MS; Broaddus RR
Mod Pathol; 2016 Nov; 29(11):1381-1389. PubMed ID: 27443514
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of mutations in BRCA and MMR genes in patients affected with hereditary endometrial cancer.
Vietri MT; D'Elia G; Caliendo G; Casamassimi A; Federico A; Passariello L; Cioffi M; Molinari AM
Med Oncol; 2021 Jan; 38(2):13. PubMed ID: 33484353
[TBL] [Abstract][Full Text] [Related]
11. Comparison of screening strategies for Lynch syndrome in patients with newly diagnosed endometrial cancer: a prospective cohort study in China.
Chao X; Li L; Wu M; Ma S; Tan X; Zhong S; Bi Y; Lang J
Cancer Commun (Lond); 2019 Jul; 39(1):42. PubMed ID: 31307542
[TBL] [Abstract][Full Text] [Related]
12. Screening for hereditary cancers in patients with endometrial cancer reveals a high frequency of germline mutations in cancer predisposition genes.
Tian W; Bi R; Ren Y; He H; Shi S; Shan B; Yang W; Wang Q; Wang H
Int J Cancer; 2019 Sep; 145(5):1290-1298. PubMed ID: 31054147
[TBL] [Abstract][Full Text] [Related]
13. Performance characteristics of screening strategies for Lynch syndrome in unselected women with newly diagnosed endometrial cancer who have undergone universal germline mutation testing.
Ferguson SE; Aronson M; Pollett A; Eiriksson LR; Oza AM; Gallinger S; Lerner-Ellis J; Alvandi Z; Bernardini MQ; MacKay HJ; Mojtahedi G; Tone AA; Massey C; Clarke BA
Cancer; 2014 Dec; 120(24):3932-9. PubMed ID: 25081409
[TBL] [Abstract][Full Text] [Related]
14. Isolated Loss of PMS2 Immunohistochemical Expression is Frequently Caused by Heterogenous MLH1 Promoter Hypermethylation in Lynch Syndrome Screening for Endometrial Cancer Patients.
Kato A; Sato N; Sugawara T; Takahashi K; Kito M; Makino K; Sato T; Shimizu D; Shirasawa H; Miura H; Sato W; Kumazawa Y; Sato A; Kumagai J; Terada Y
Am J Surg Pathol; 2016 Jun; 40(6):770-6. PubMed ID: 26848797
[TBL] [Abstract][Full Text] [Related]
15. Mismatch Repair Universal Screening of Endometrial Cancers (MUSE) in a Canadian Cohort.
Lawrence J; Richer L; Arseneau J; Zeng X; Chong G; Weber E; Foulkes W; Palma L
Curr Oncol; 2021 Jan; 28(1):509-522. PubMed ID: 33467402
[TBL] [Abstract][Full Text] [Related]
16. A study of over 35,000 women with breast cancer tested with a 25-gene panel of hereditary cancer genes.
Buys SS; Sandbach JF; Gammon A; Patel G; Kidd J; Brown KL; Sharma L; Saam J; Lancaster J; Daly MB
Cancer; 2017 May; 123(10):1721-1730. PubMed ID: 28085182
[TBL] [Abstract][Full Text] [Related]
17. Universal screening for Lynch syndrome in endometrial cancers: frequency of germline mutations and identification of patients with Lynch-like syndrome.
Dillon JL; Gonzalez JL; DeMars L; Bloch KJ; Tafe LJ
Hum Pathol; 2017 Dec; 70():121-128. PubMed ID: 29107668
[TBL] [Abstract][Full Text] [Related]
18. Prospective Statewide Study of Universal Screening for Hereditary Colorectal Cancer: The Ohio Colorectal Cancer Prevention Initiative.
Pearlman R; Frankel WL; Swanson BJ; Jones D; Zhao W; Yilmaz A; Miller K; Bacher J; Bigley C; Nelsen L; Goodfellow PJ; Goldberg RM; Paskett E; Shields PG; Freudenheim JL; Stanich PP; Lattimer I; Arnold M; Prior TW; Haut M; Kalady MF; Heald B; Paquette I; Draper DJ; Brell JM; Mahesh S; Weeman K; Bastola S; Zangmeister J; Gowda A; Kencana F; Malcolm A; Liu Y; Cole S; Bane C; Li C; Rehmus E; Pritchard CC; Shirts BH; Jacobson A; Cummings SA; de la Chapelle A; Hampel H
JCO Precis Oncol; 2021; 5():. PubMed ID: 34250417
[TBL] [Abstract][Full Text] [Related]
19. Lynch syndrome identification in a Brazilian cohort of endometrial cancer screened by a universal approach.
Rosa RCA; Santis JO; Teixeira LA; Molfetta GA; Dos Santos JTT; Ribeiro VDS; Chahud F; Ribeiro-Silva A; Brunaldi MO; Silva WA; Ferraz VEF
Gynecol Oncol; 2020 Oct; 159(1):229-238. PubMed ID: 32694065
[TBL] [Abstract][Full Text] [Related]
20. Universal screening of both endometrial and colon cancers increases the detection of Lynch syndrome.
Adar T; Rodgers LH; Shannon KM; Yoshida M; Ma T; Mattia A; Lauwers GY; Iafrate AJ; Hartford NM; Oliva E; Chung DC
Cancer; 2018 Aug; 124(15):3145-3153. PubMed ID: 29750335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
